EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Digital Transformation and Innovation in the U.S. Pharmaceutical Industry
Something fundamental has shifted inside American pharmaceutical companies over the past few years The clipboards are gone The manual logbooks have been replaced by sensors dashboards and predictive alerts that flag problems before they happen This shift didnt occur overnight but it has accelerated dramatically as competitive pressure and patient expectations have both risen
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
CAVE-Onc: Graph-constrained agentic validation for cross-domain contradictions in CDISC oncology submissions
The CDISC Rules Engine CORE provides industrystandard validation for Study Data Tabulation Model SDTM submissions yet its imperative domainscoped architecture cannot express crossdomain contradictions
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Artificial Intelligence for the Digital Revolution of Pharmaceutical Manufacturing
Ravendra Singh
The pharmaceutical industry is currently undergoing a paradigm shift from traditional manufacturing to AI-powered manufacturing. However, there are distinct challenges and complexities that must be ad...
-
2
ABM Pharma Tactics US: Unlocking B2B Lead Gen Success
Kate Williamson
The Account-based marketing (ABM) pharma strategies are reshaping the US B2B pharma marketing by focusing the high value accounts rather than the lead volume. Pharmaceutical account-based marketing en...
-
3
Revolutionizing Medicine: The Power of Pharmaceutical Nanotechnology
Kate Williamson
Revolutionizing Medicine: The Power of Pharmaceutical Nanotechnology explores the transformative impact of nanotechnology on healthcare, including targeted drug delivery, personalized medicine, and in...
-
4
Foundation Models in Drug Discovery: The Next Frontier of Pharmaceutical Research
Lakshmi
Foundation models pretrained on vast biological corpora are replacing the one-model-per-task economics that has long limited computational drug discovery. This article explains what makes these system...
-
5
U.S. Pharmaceutical Business Strategy: FDA Regulation, Innovation, Outsourcing and Market Growth
Kate Williamson
U.S. pharmaceutical companies face mounting pressure from patent cliffs, pricing scrutiny, and global supply chain risk. This article outlines an integrated growth strategy—linking FDA regulator...
press releasesRead more...
Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines
Gilead Sciences Inc Nasdaq GILD today celebrated the opening of its squarefoot Research Center at its Foster City headquarters expanding capabilities in oncology inflammation and research data
Flow Technology partners with BW Forsyth Partners to Meet Growing Demand for Biopharmaceutical Manufacturing
Flow Technology a provider of engineered process systems and skid integration solutions serving the global life sciences industry announced a partnership with BW Forsyth Partners that will support the companys
Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
Definium Therapeutics Inc Definium or the Company a latestage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric
Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)
Intellia Therapeutics Inc Nasdaq NTLA a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies today announced the US
Events Read more...
09 - 10
Sep 2026iPSC Drug Development Summit
Hyatt Regency Boston Harbour,...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
LATEST NEWSRead more...
Sernova and Seraxis to Merge and Form BetaNova Biotherapeutics for Type 1 Diabetes Cell Replacement
Sernova Biotherapeutics Inc and Seraxis Holdings Inc have entered into a definitive merger agreement to combine their technologies and create BetaNova Biotherapeutics a clinicalstage biotechnology
RiboX Therapeutics Receives FDA RMAT Designation for RXRG001
RiboX Therapeutics has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for RXRG an investigational treatment
Lupin receives US FDA approval for Modafinil tablets
Lupin has received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Modafinil Tablets USP mg and mg
AtomVie opens new radiopharmaceutical manufacturing facility in Ontario
AtomVie Global Radiopharma AtomVie a contract development and manufacturing organisation CDMO specialising in radiopharmaceuticals has opened a new manufacturing facility in Hamilton Ontario
FDA Approves First Drug to Treat Alexander Disease
The US Food and Drug Administration FDA has approved Zanvastro zilganersen injection for the treatment of Alexander disease in paediatric and adult patients It is the first FDAapproved treatment
AbbVie Completes Acquisition of Apogee Therapeutics
AbbVie has completed its acquisition of Apogee Therapeutics bringing the biotechnology company and its pipeline of antibodybased treatments into AbbVie
